This global consulting and advisory services firm recently picked up a 4-year task with the Food and Drug Administration Center for Drug Evaluation and Research to provide a range of Business Intelligence and Publishing support services to this center charged with regulating over-the-counter and prescription drugs, including biological therapeutics and generic drugs.
The post FDA awards 29M CDER Business Intelligence and Publishing Support task to Deloitte appeared first on G2Xchange Health.
